Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels

Emily Kronsteiner, Richard W. Lee, John P. Sweeney, Jennifer R. Metallo, James D. Stoehr, F. David Fortuin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: Compare outcomes of hybrid bare-metal stent (BMS)/sirolimus-eluting stent (SES) to BMS alone for the treatment of stenoses in small coronary arteries. Background: One approach to potentially reduce the risk of restenosis in long lesions with smaller distal reference diameters is to use a small (2.0-2.5mm) "BMS cap" (BMC) distally, telescoped in tandem with a SES(s) proximally, matched to a proximal segment where the diameter is ≥ 2.5 mm (creating a BMC/SES hybrid stent). Results from previous reports using "hybrid" drug-eluting stents and BMS are mixed. Methods: We performed a retrospective analysis of BMC/SES cases in small vessels at our institution and compared the outcomes with a control group (BMS) consisting of patients treated with at least one 2.0-2.5 mm BMS. Results: During the years 2003-2006, 41 BMC/SES and 62 BMS cases were identified and follow up was available in 33 and 49 patients, respectively. Baseline demographics, procedure indications and pertinent discharge medications for the two groups were similar. Despite the use of more stents and longer total stent length in the BMC/SES group compared to the BMS group (2.9 ± 0.79 vs. 1.4 ± 0.69 and 64 ± 21 mm vs. 26 ± 18 mm; p < 0.0001 for both comparisons), there was a significant decrease in the composite of restenosis, myocardial infarction and cardiac death (9% vs. 29%; p ≤ 0.033). Conclusions: The use of a "BMS cap" distally, telescoped in tandem with SES more proximally, may be a reasonable approach in treating long lesions in coronary arteries with distal reference diameters ≤ 2.5 mm.

Original languageEnglish (US)
Pages (from-to)76-79
Number of pages4
JournalJournal of Invasive Cardiology
Volume22
Issue number2
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Sirolimus
Stents
Coronary Vessels
Metals
Telescopes
Drug-Eluting Stents

Keywords

  • Coronary artery stenosis
  • Coronary disease
  • Drug-coated stents
  • Stents

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Kronsteiner, E., Lee, R. W., Sweeney, J. P., Metallo, J. R., Stoehr, J. D., & Fortuin, F. D. (2010). Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels. Journal of Invasive Cardiology, 22(2), 76-79.

Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels. / Kronsteiner, Emily; Lee, Richard W.; Sweeney, John P.; Metallo, Jennifer R.; Stoehr, James D.; Fortuin, F. David.

In: Journal of Invasive Cardiology, Vol. 22, No. 2, 02.2010, p. 76-79.

Research output: Contribution to journalArticle

Kronsteiner, E, Lee, RW, Sweeney, JP, Metallo, JR, Stoehr, JD & Fortuin, FD 2010, 'Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels', Journal of Invasive Cardiology, vol. 22, no. 2, pp. 76-79.
Kronsteiner, Emily ; Lee, Richard W. ; Sweeney, John P. ; Metallo, Jennifer R. ; Stoehr, James D. ; Fortuin, F. David. / Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels. In: Journal of Invasive Cardiology. 2010 ; Vol. 22, No. 2. pp. 76-79.
@article{926e75becf4b41a09d84c9272f240575,
title = "Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels",
abstract = "Objectives: Compare outcomes of hybrid bare-metal stent (BMS)/sirolimus-eluting stent (SES) to BMS alone for the treatment of stenoses in small coronary arteries. Background: One approach to potentially reduce the risk of restenosis in long lesions with smaller distal reference diameters is to use a small (2.0-2.5mm) {"}BMS cap{"} (BMC) distally, telescoped in tandem with a SES(s) proximally, matched to a proximal segment where the diameter is ≥ 2.5 mm (creating a BMC/SES hybrid stent). Results from previous reports using {"}hybrid{"} drug-eluting stents and BMS are mixed. Methods: We performed a retrospective analysis of BMC/SES cases in small vessels at our institution and compared the outcomes with a control group (BMS) consisting of patients treated with at least one 2.0-2.5 mm BMS. Results: During the years 2003-2006, 41 BMC/SES and 62 BMS cases were identified and follow up was available in 33 and 49 patients, respectively. Baseline demographics, procedure indications and pertinent discharge medications for the two groups were similar. Despite the use of more stents and longer total stent length in the BMC/SES group compared to the BMS group (2.9 ± 0.79 vs. 1.4 ± 0.69 and 64 ± 21 mm vs. 26 ± 18 mm; p < 0.0001 for both comparisons), there was a significant decrease in the composite of restenosis, myocardial infarction and cardiac death (9{\%} vs. 29{\%}; p ≤ 0.033). Conclusions: The use of a {"}BMS cap{"} distally, telescoped in tandem with SES more proximally, may be a reasonable approach in treating long lesions in coronary arteries with distal reference diameters ≤ 2.5 mm.",
keywords = "Coronary artery stenosis, Coronary disease, Drug-coated stents, Stents",
author = "Emily Kronsteiner and Lee, {Richard W.} and Sweeney, {John P.} and Metallo, {Jennifer R.} and Stoehr, {James D.} and Fortuin, {F. David}",
year = "2010",
month = "2",
language = "English (US)",
volume = "22",
pages = "76--79",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "HMP Communications",
number = "2",

}

TY - JOUR

T1 - Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels

AU - Kronsteiner, Emily

AU - Lee, Richard W.

AU - Sweeney, John P.

AU - Metallo, Jennifer R.

AU - Stoehr, James D.

AU - Fortuin, F. David

PY - 2010/2

Y1 - 2010/2

N2 - Objectives: Compare outcomes of hybrid bare-metal stent (BMS)/sirolimus-eluting stent (SES) to BMS alone for the treatment of stenoses in small coronary arteries. Background: One approach to potentially reduce the risk of restenosis in long lesions with smaller distal reference diameters is to use a small (2.0-2.5mm) "BMS cap" (BMC) distally, telescoped in tandem with a SES(s) proximally, matched to a proximal segment where the diameter is ≥ 2.5 mm (creating a BMC/SES hybrid stent). Results from previous reports using "hybrid" drug-eluting stents and BMS are mixed. Methods: We performed a retrospective analysis of BMC/SES cases in small vessels at our institution and compared the outcomes with a control group (BMS) consisting of patients treated with at least one 2.0-2.5 mm BMS. Results: During the years 2003-2006, 41 BMC/SES and 62 BMS cases were identified and follow up was available in 33 and 49 patients, respectively. Baseline demographics, procedure indications and pertinent discharge medications for the two groups were similar. Despite the use of more stents and longer total stent length in the BMC/SES group compared to the BMS group (2.9 ± 0.79 vs. 1.4 ± 0.69 and 64 ± 21 mm vs. 26 ± 18 mm; p < 0.0001 for both comparisons), there was a significant decrease in the composite of restenosis, myocardial infarction and cardiac death (9% vs. 29%; p ≤ 0.033). Conclusions: The use of a "BMS cap" distally, telescoped in tandem with SES more proximally, may be a reasonable approach in treating long lesions in coronary arteries with distal reference diameters ≤ 2.5 mm.

AB - Objectives: Compare outcomes of hybrid bare-metal stent (BMS)/sirolimus-eluting stent (SES) to BMS alone for the treatment of stenoses in small coronary arteries. Background: One approach to potentially reduce the risk of restenosis in long lesions with smaller distal reference diameters is to use a small (2.0-2.5mm) "BMS cap" (BMC) distally, telescoped in tandem with a SES(s) proximally, matched to a proximal segment where the diameter is ≥ 2.5 mm (creating a BMC/SES hybrid stent). Results from previous reports using "hybrid" drug-eluting stents and BMS are mixed. Methods: We performed a retrospective analysis of BMC/SES cases in small vessels at our institution and compared the outcomes with a control group (BMS) consisting of patients treated with at least one 2.0-2.5 mm BMS. Results: During the years 2003-2006, 41 BMC/SES and 62 BMS cases were identified and follow up was available in 33 and 49 patients, respectively. Baseline demographics, procedure indications and pertinent discharge medications for the two groups were similar. Despite the use of more stents and longer total stent length in the BMC/SES group compared to the BMS group (2.9 ± 0.79 vs. 1.4 ± 0.69 and 64 ± 21 mm vs. 26 ± 18 mm; p < 0.0001 for both comparisons), there was a significant decrease in the composite of restenosis, myocardial infarction and cardiac death (9% vs. 29%; p ≤ 0.033). Conclusions: The use of a "BMS cap" distally, telescoped in tandem with SES more proximally, may be a reasonable approach in treating long lesions in coronary arteries with distal reference diameters ≤ 2.5 mm.

KW - Coronary artery stenosis

KW - Coronary disease

KW - Drug-coated stents

KW - Stents

UR - http://www.scopus.com/inward/record.url?scp=76749157456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76749157456&partnerID=8YFLogxK

M3 - Article

C2 - 20124593

AN - SCOPUS:76749157456

VL - 22

SP - 76

EP - 79

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 2

ER -